# Amiodarone

## Amiodarone (Cordarone) inj 150mg/3mL

##### 

| TAH Drug Code      | IAMIO                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Wolff-Parkinson-White syndrome, supraventricular & ventricular tachycardia, atrial & ventricular fibrillation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Dosing             | Must be administered using a volumetric infusion pump preferably via a central venous catheter. Initially 5 mg/kg in 250 mL of dextrose 5% IV infusion for 20 minutes to 2 hours. May repeat 2-3 times in 24 hours. Maintenance dose: 10-20 mg/kg (usually 600-800 mg/24 hours, maximum: 1.2 gm/24 hours) in 250 mL dextrose IV infusion. Cardiopulmonary resuscitation, Ventricular fibrillation/pulseless ventricular tachycardia: 300 mg IV by rapid infusion; a single dose of 150 mg IV may be repeated if Ventricular fibrillation/pulseless ventricular tachycardia recurs.                                                                                                                                                                                                                                                                                        |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | AV or SA block, sinus bradycardia, sick sinus syndrome except when used in conjunction with a pacemaker; history of thyroid dysfunction; iodine intolerance, severe arterial hypotension, CV collapse, acute cardiac insufficiency. Combined therapy with drugs which may induce torsades de pointes. Pregnancy, lactation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Adverse Effects    | Hot flushes, sweating, nausea, moderate transient hypotension, moderate bradycardia, arrhythmia, elevation of transaminases. May impair hepatic function. Cardiovascular: Bradyarrhythmia, Hypotension (oral, less than 1%; intravenous, 15.6% ) Dermatologic: Photodermatitis (2% to 24% ), Photosensitivity (3% to 10% ) Endocrine metabolic: Thyroid dysfunction Gastrointestinal: Constipation (4% to 9% ), Loss of appetite (4% to 9% ), Nausea (10% to 33% ), Vomiting (10% to 33% ) Hepatic: Increased liver enzymes (4% to 9% ) Neurologic: Abnormal gait (4% to 9% ), Coordination problem (4% to 9% ), Dizziness (4% to 9% ), Involuntary movement (4% to 9% ), Movement disorder (4% to 9% ), Paresthesia (4% to 9% ), Peripheral neuropathy Ophthalmic: Corneal deposit, Microdeposits, Visual disturbance (4% to 9% ) Other: Malaise and fatigue (4% to 9% ) |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | No (Limited) Human Data – Potential Toxicity(Mother)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

## Cordarone 200mg

##### 

| TAH Drug Code      | OAMIO                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Wolff-Parkinson-White syndrome, supraventricular & ventricular tachycardia, atrial & ventricular fibrillation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | Initial dose: 600mg/day in divided doses for 8-10 days. Maintenance dose: dosage range from 100mg daily (200 mg every other day) to 400 mg/day.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | AV or SA block, sinus bradycardia, sick sinus syndrome except when used in conjunction with a pacemaker; history of thyroid dysfunction; iodine intolerance, severe arterial hypotension, CV collapse, acute cardiac insufficiency. Combined therapy with drugs which may induce torsades de pointes. Pregnancy, lactation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | Hypersensitivity, headache, joint pain, bradycardia, pigmentation, photosensitization, transient hypotension, face flush, sweating & transient nausea. Cardiovascular: Bradyarrhythmia, Hypotension (oral, less than 1%; intravenous, 15.6% ) Dermatologic: Photodermatitis (2% to 24% ), Photosensitivity (3% to 10% ) Endocrine metabolic: Thyroid dysfunction Gastrointestinal: Constipation (4% to 9% ), Loss of appetite (4% to 9% ), Nausea (10% to 33% ), Vomiting (10% to 33% ) Hepatic: Increased liver enzymes (4% to 9% ) Neurologic: Abnormal gait (4% to 9% ), Coordination problem (4% to 9% ), Dizziness (4% to 9% ), Involuntary movement (4% to 9% ), Movement disorder (4% to 9% ), Paresthesia (4% to 9% ), Peripheral neuropathy Ophthalmic: Corneal deposit, Microdeposits, Visual disturbance (4% to 9% ) Other: Malaise and fatigue (4% to 9% ) |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

